Panel: Getting Your Molecule Thru the Clinic in these Challenging Times- a View from Partners’ C-Suite
Industry leaders are poised to innovate further, but against a backdrop where complexity is increasing exponentially, “money” is more expensive, and stakeholders are acutely aware of the pressure to move faster. But we have seen first-hand, for example, with our pandemic response and finding a cure for hepatitis C, what can be accomplished when the ecosystem works together for the benefit of all, and especially for patients.
Brought to you by Orientation Marketing, hear thought-provoking views from five experienced c-level executives from leading development, technology, manufacturing, and bioprocessing partners. Each is tasked with navigating ever-evolving deal dynamics, complex development, analytical, formulation and manufacturing approaches across many more modalities, and a regulatory landscape forever changed by the pandemic, and racing to keep pace with accelerating innovation.
As we face the journey toward more personalised treatments and an AI-empowered future, prepare to be enlightened, informed, and inspired.
Expert Insights have partnered with Orientation Marketing to extend the world-leading solutions they provide to the pharma services sector with the addition of marketing strategy, media relations, content, digital and creative flair. The partnership reflects the companies’ shared philosophy of leveraging the expertise and experience of senior life-sciences executives to deliver practical, high ROI, integrated growth solutions to clients, and accelerate transformation and growth.
Moderators
Dr. Kurt Nielsen
Managing Partner, Expert Insights Consulting
Dr. Kurt Nielsen, a veteran industry executive and currently a Managing Partner at Expert Insights Consulting, a top advisory firm for Pharma Services firms and investors, and an Orientation Marketing strategic partner. Kurt has previously served in a variety of product development and executive roles including CEO at Pii, CTO at Catalent, President at Lupin Somerset, a division of Lupin Inc., and as well as SVP Launch Management and Commercialization at Sandoz, Inc and EVP of Pharmaceuticals at URL Pharma.
Speakers
William Humphries
Alcami, CEO
Prior to Alcami, Humphries’ executive leadership roles included CEO at Isosceles Pharmaceuticals, President and Group Company Chairman of Ortho-Dermatologics, CEO of Merz North America, President of Stiefel, a GSK Company and Vice President of US Skincare at Allergan Pharmaceuticals.
Christian Jones
CCO, Nanoform
Christian is the Chief Commercial Officer for Nanoform and leads the business activities for the company. In his role he works with Pharma and Biotech partners to bring their drug molecules back to life by rapidly improving their solubility and bioavailability through the application of Nanoform’s proprietary solution to nanoparticle technology.
Hayley Crowe
Executive Vice President and General Manager, Global Life Sciences, Ecolab
Hayley Crowe is executive vice president and general manager of Ecolab’s Global Life Sciences sector, comprised of Ecolab’s Purolite and Pharma/Personal Care businesses and responsible for delivering value to our pharmaceutical and biotechnology customers with innovative downstream purification products and manufacturing decontamination solutions.
Dan Smithey, PhD
President, CEO and Co-founder, Serán BioScience
Dr. Smithey is the President, CEO and Co-founder of Serán BioScience. Over his 30-year career, he has led multiple research and development projects in a broad range of therapeutic areas. His work has led to the successful development of several novel medicines, including Tucatinib for the treatment of metastatic breast cancer.
For more, please find the original story source here.
